The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in Maryland. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. Since 2007, MSCRF has invested close to $200 million in accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Discover how the Maryland Stem Cell Research Fund Accelerates Cures here.

Below is a list of our most current awardees.

Awardees

2025

2024

Commercialization
Dr. Mandeep Singh

Agnos Therapeutics, Inc.

Development of Cellular Component Transfer (CCT) as a Treatment to Restore Vision in Retinitis Pigmentosa

Post-Doctoral Fellowship
Dr. Cristina Zivko

Mentor: Dr. Vasiliki Machairaki

MALDI-Imaging of iPSC-Derived Hindbrain Organoids as in Vitro Models for Alzheimer’s Disease and Drug Screenings

Manufacturing Assistance
Dr. Evelyn Chukwurah

Enhancement of Capabilities of Existing Cytocentric Xvivo System Model 2 from
BioSpherix

2023

2022

Discovery
Dr. Srinivasa Rao Sripathi

High-Throughput Screen For Small Molecules That Inhibit RPE-EMT as an Approach for Treatment of  AMD

Launch
Dr. Patrick Cahan

Distilling Predictive Models of Human Stem Cell Fate Control from Single Cell Omics Data

2021

Post-Doctoral Fellowship
Dr. Bo Am Seo

Mentor: Dr. Hanseok Ko

Neurotoxic Astrocyte Secreted-ExoDrp1 Causes Excessive Mitochondrial Fragmentation and Neurodegeneration of Human Dopaminergic Neurons

2020

Annual Reports

Annual reports include profiles and details on past MSCRF awardees, the MSCR Commission, and closed grant awardees.